메뉴 건너뛰기
Radiotherapy and Oncology
Volumn 90, Issue 2, 2009, Pages 280-281
Late onset of skin toxicity induced by EGFr-inhibitors
Author keywords

[No Author keywords available]
Indexed keywords

CETUXIMAB; CISPLATIN; DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; NIMORAZOLE; UNCLASSIFIED DRUG; ZALUTUMUMAB;
EID: 59649125194     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.10.014     Document Type: Letter
Times cited : (11)
References (6)
  • 1
    • 21344462378 scopus 로고    scopus 로고
    • Cutaneous side-effects of kinase inhibitors and blocking antibodies
    • Robert C., Soria J.C., Spatz A., et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 6 (2005) 491-500
    • (2005) Lancet Oncol , vol.6 , pp. 491-500
    • Robert, C.1    Soria, J.C.2    Spatz, A.3
  • 2
    • 32144433159 scopus 로고    scopus 로고
    • Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    • Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
    • (2006) N Engl J Med , vol.354 , pp. 567-578
    • Bonner, J.A.1    Harari, P.M.2    Giralt, J.3
  • 3
    • 34547645422 scopus 로고    scopus 로고
    • Severe cutaneous reaction during radiation therapy with concurrent cetuximab
    • Budach W., Bolke E., and Homey B. Severe cutaneous reaction during radiation therapy with concurrent cetuximab. N Engl J Med 357 (2007) 514-515
    • (2007) N Engl J Med , vol.357 , pp. 514-515
    • Budach, W.1    Bolke, E.2    Homey, B.3
  • 4
    • 59649119961 scopus 로고    scopus 로고
    • Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer
    • Pryor D.I., Porceddu S.V., Burmeister B.H., et al. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiother Oncol 90 (2009) 172-176
    • (2009) Radiother Oncol , vol.90 , pp. 172-176
    • Pryor, D.I.1    Porceddu, S.V.2    Burmeister, B.H.3
  • 5
    • 59649123356 scopus 로고    scopus 로고
    • High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes
    • Giro C., Berger B., Bölke E., et al. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes. Radiother Oncol 90 (2009) 166-171
    • (2009) Radiother Oncol , vol.90 , pp. 166-171
    • Giro, C.1    Berger, B.2    Bölke, E.3
  • 6
    • 39049165254 scopus 로고    scopus 로고
    • Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
    • Bernier J., Bonner J., Vermorken J.B., et al. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 19 (2008) 142-149
    • (2008) Ann Oncol , vol.19 , pp. 142-149
    • Bernier, J.1    Bonner, J.2    Vermorken, J.B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.